High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of

Stephanie Bezzina Wettinger1, Carine J M Doggen, C Arnold Spek

  • 1Laboratory for Experimental Internal Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Blood
|November 4, 2004
PubMed

Insights

This study reveals that white blood cells in myocardial infarction patients exhibit heightened inflammatory gene activity. Key indicators include elevated messenger RNA for macrophage migration inhibitory factor and proteinase inhibitor 9, suggesting inflammation

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Molecular Biology

Background:

  • Traditional cardiovascular disease inflammation markers are influenced by multiple factors.
  • Direct measurement of inflammatory gene expression in leukocytes offers a more precise approach.

Purpose of the Study:

  • To investigate the inflammatory mRNA profile of leukocytes in myocardial infarction patients.
  • To identify specific inflammatory genes associated with myocardial infarction risk.

Main Methods:

  • A case-control study involving 524 men with myocardial infarction and 628 controls.
  • Analysis of mRNA profiles for 35 inflammatory markers in blood leukocytes using a multigene system.

Main Results:

  • Patients with myocardial infarction showed increased mRNA levels for most inflammatory markers compared to controls.
  • Elevated messenger RNA (mRNA) for macrophage migration inhibitory factor and proteinase inhibitor 9 were the strongest indicators of risk.
  • A dose-response relationship was observed, with higher mRNA levels correlating with increased risk.

Conclusions:

  • Leukocytes in myocardial infarction patients display enhanced inflammatory gene transcription.
  • These findings support the role of leukocyte-mediated inflammation in the pathogenesis of myocardial infarction.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...